Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 114,549 | reported | 05 Mar 2026 | tx 12+202,139−2,009 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | SALE | Metagenomi Therapeutics, Inc. | 482 | 1.60 USD | |
| 05 Dec 2025 | SALE | Metagenomi Therapeutics, Inc. | 199 | 1.77 USD | |
| 05 Sept 2025 | SALE | Metagenomi Therapeutics, Inc. | 199 | 1.81 USD | |
| 01 Dec 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 96,000 | 1.60 USD | |
| 06 Jun 2025 | SALE | Metagenomi Therapeutics, Inc. | 199 |
| 1.75 USD |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 3,775 | 0.00 USD |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 3,650 | 0.00 USD |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 21,875 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 22,725 | 0.00 USD | deriv |
| 05 Mar 2025 | SALE | Metagenomi Therapeutics, Inc. | 930 | 1.87 USD |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 10,397 | 0.00 USD |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 43,717 | 0.00 USD | deriv |